Veru (VERU) Revenue (2012 - 2024)
Veru (VERU) posted quarterly Revenue of $4.5 million for Q4 2024, up 109.49% year-over-year from $2.1 million in Q1 2024, and down 32.63% quarter-over-quarter from $6.7 million in Q3 2024.
Veru (VERU) Revenue (2012 - 2024) Analysis & Trends
Veru (VERU) has reported Revenue for 13 consecutive years, with $4.5 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Revenue rose 109.49% year-over-year to $4.5 million; the TTM figure through Sep 2025 stood at $4.5 million (down 73.44% YoY), while the FY2025 annual figure was $4.5 million, down 73.44% from the prior year.
- Revenue declined to $4.5 million in Q4 2024 per VERU's latest filing, from $6.7 million in the prior quarter.
- Across five years, Revenue topped out at $15.6 million in Q3 2021 and bottomed at -$30.3 million in Q3 2020.
- Historically, Revenue has averaged $3.2 million across 5 years, with a median of $3.6 million in 2023.
- Annual changes were most pronounced in 2020 — Revenue plunged 99.27% — and 2021, when it jumped 2744.45%.
- Veru's Revenue stood at $604000.0 in 2020, then slumped by 65.4% to $209000.0 in 2021, then jumped by 1099.9% to $2.5 million in 2022, then dropped by 14.64% to $2.1 million in 2023, then soared by 109.49% to $4.5 million in 2024.
- Business Quant data shows VERU's Revenue at $4.5 million in Q4 2024, $6.7 million in Q3 2024, and $4.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.48 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 3.95 Mn |
| Mar 31, 2024 | 4.14 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 6.59 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 2.59 Mn |
| Jun 30, 2022 | 9.60 Mn |
| Mar 31, 2022 | 13.03 Mn |
| Dec 31, 2021 | 209,000.00 |
| Sep 30, 2021 | 15.65 Mn |
| Jun 30, 2021 | 1.37 Mn |
| Mar 31, 2021 | 13.34 Mn |
| Dec 31, 2020 | 604,000.00 |
| Sep 30, 2020 | -30.29 Mn |
| Jun 30, 2020 | 169,000.00 |
| Mar 31, 2020 | 469,000.00 |